We received extensive coverage of several studies on Sunday 11 May.
Although there are stories in many languages, most of the articles are in English as that is the congress language.

SURMOUNT-5 published in NEJM - First head-to-head study in people living with obesity shows tirzepatide results in around 50% more weight loss than semaglutide

Dr Louis J Aronne, Director of the Comprehensive Weight Control Center at Weill Cornell Medicine, New York, New York, USA, and colleagues

Reuters - Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial | Reuters
Washington Post (USA) - Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs - The Washington Post
Fortune Magazine (USA) - Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study | Fortune
Good Morning America - https://www.goodmorningamerica.com/wellness/video/study-finds-zepbound-people-lose-weight-wegovy-121705853
ABC News (USA) - https://abcnews.go.com/Business/wireStory/zepbound-beats-wegovy-weight-loss-head-head-trial-121696324

BBC - Rival weight loss drugs go head-to-head with clear winner
Bloomberg - Eli Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy in Study - Bloomberg
AP newswire - Zepbound Outperforms Wegovy in First Comparative Trial of Weight-Loss Drugs | AP News

G1 (Brazilian news portal) - Wegovy or Mounjaro? Scientists Compare the Two and Show Which Weight Loss Remedy Is Better | Health | G1
O Globo (Brazil) - Mounjaro or Wegovy: which is the best medicine to lose weight? New study answers

GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

Dr Yael Wolff Sagy from Clalit Health Services, Tel-Aviv, Israel and Professor Dror Dicker, Hasharon Hospital, Rabin Medical Center, Petah Tikva, Israel and colleagues

Daily Telegraph (national newspaper UK) - Weight-loss jabs ‘halve the risk of cancer’
The Times (national newspaper UK) - Weight-loss drugs herald new era of cancer prevention
Guardian (national newspaper UK) - Weight-loss jabs could halve risk of obesity-related cancers, study finds | Obesity | The Guardian
The Sun (national newspaper UK) - Fat jabs slash risk of silent killer which affects thousands of Brits a year by HALF, incredible study finds | The Sun
The Mirror (national newspaper UK) - Weight loss jabs like Wegovy and Mounjaro may have anti-cancer effect 'beyond weight loss' - The Mirror
Daily Express (USA) - Weight loss shots could 'herald new era' in cancer prevention, expert says - Health - News - Daily Express US
Daily Express (UK) - Weight loss jabs 'could nearly halve the risk of cancer' | UK | News | Express.co.uk

First five years of a child’s life provide a critical window of opportunity for preventing overweight and obesity, Dutch study suggests

Jasmin De Groot, Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands and colleages

First 5 years child’s life key preventing obesity Guardian (national newspaper UK) -Being overweight as a young child could double risk of adult obesity, research shows | Obesity | The Guardian
The Times (national newspaper UK) - Child’s BMI aged six predicts likelihood of obesity as an adult
PA newswire, as seen in 100s of outlets across the UK, including:
The Independent(national newspaper UK)  - First five years of life key to preventing obesity, researchers suggest | The Independent

Day Three Articles

    Day Three Videos